These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11883089)

  • 1. Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes.
    Rubinchik S; Norris JS; Dong JY
    Methods Enzymol; 2002; 346():529-47. PubMed ID: 11883089
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.
    Hyer ML; Voelkel-Johnson C; Rubinchik S; Dong J; Norris JS
    Mol Ther; 2000 Oct; 2(4):348-58. PubMed ID: 11020350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system.
    Rubinchik S; Ding R; Qiu AJ; Zhang F; Dong J
    Gene Ther; 2000 May; 7(10):875-85. PubMed ID: 10845726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.
    Rubinchik S; Woraratanadharm J; Yu H; Dong JY
    Gene Ther; 2005 Mar; 12(6):504-11. PubMed ID: 15660114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of adenoviral vectors.
    Davis AR; Wivel NA; Palladino JL; Tao L; Wilson JM
    Mol Biotechnol; 2001 May; 18(1):63-70. PubMed ID: 11439700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and function of a recombinant adenovirus encoding a human aquaporin 1-green fluorescent protein fusion product.
    Hoque AT; Liu X; Kagami H; Swaim WD; Wellner RB; O'Connell BC; Ambudkar IS; Baum BJ
    Cancer Gene Ther; 2000 Mar; 7(3):476-85. PubMed ID: 10766354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of adenoviral vectors. Analysis of eye development.
    Bennett J; Zeng Y; Gupta AR; Maguire AM
    Methods Mol Biol; 2000; 135():525-35. PubMed ID: 10791347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Construction of a recombinant adenovirus vector for interferon-gamma-inducible protein 10 and the adenovirus preparation].
    Shao ZY; Liu ZF; Peng Y; Xu J; Deng P; Jiang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1552-5. PubMed ID: 17121697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
    Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
    Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
    Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.
    Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR
    Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved production of adenovirus vectors expressing apoptotic transgenes.
    Bruder JT; Appiah A; Kirkman WM; Chen P; Tian J; Reddy D; Brough DE; Lizonova A; Kovesdi I
    Hum Gene Ther; 2000 Jan; 11(1):139-49. PubMed ID: 10646646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new method for construction of EGFP-labled recombinant adenovirus containing hVEGF(165) and its property in vitro].
    Zhong ZD; Zou P; Huang SA; Hu ZB; Liu LB; Lu YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):238-42. PubMed ID: 12844403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells.
    Gao G; Zhou X; Alvira MR; Tran P; Marsh J; Lynd K; Xiao W; Wilson JM
    Gene Ther; 2003 Oct; 10(22):1926-30. PubMed ID: 14502222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of the recombinant adenovirus vector bearing dual-survivin shRNA].
    Gao P; Shan YX; Yang DR
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):324-7. PubMed ID: 18481424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green fluorescent protein-tagged Ras proteins for intracellular localization.
    Choy E; Philips M
    Methods Enzymol; 2001; 332():50-64. PubMed ID: 11305117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.